$3.11
0.124.01%
最終更新: Oct 23, 8:16 AM
Benzinga
Benzinga
Benzinga
金曜日, 10 23
Benzinga
© 2026 Benzinga | All Rights Reserved
Addex Therapeutics (ADXN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-2.16 | $-1.53 | $-1.50 | $-1.50 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $12650 | $10214 | $20020 | $62500 |
| Surprise | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q3 | Nov 4, 2021 | $-14.40 | $-14.40 | 0.00 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Sep 30, 2024 | $127.15K | $ | -51.1 % |
| Q3 | Nov 29, 2023 | $370.87K | $700.00K | -47.0 % |
| Q3 | Nov 4, 2021 | $825.37K | $420.00K | 96.5 % |